Donald Frail - Net Worth and Insider Trading

Donald Frail Net Worth

The estimated net worth of Donald Frail is at least $4 Million dollars as of 2025-04-30. Donald Frail is the Director of Pandion Therapeutics Inc and owns about 61,113 shares of Pandion Therapeutics Inc (PAND) stock worth over $4 Million. Details can be seen in Donald Frail's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Donald Frail has not made any transactions after 2020-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Donald Frail

To

Donald Frail Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald Frail owns 1 companies in total, including Pandion Therapeutics Inc (PAND) .

Click here to see the complete history of Donald Frail’s form 4 insider trades.

Insider Ownership Summary of Donald Frail

Ticker Company Transaction Date Type of Owner
PAND Pandion Therapeutics Inc 2020-07-21 director

Donald Frail Latest Holdings Summary

Donald Frail currently owns a total of 1 stock. Donald Frail owns 61,113 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $4 Million.

Latest Holdings of Donald Frail

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PAND Pandion Therapeutics Inc 2020-07-21 61,113 60.05 3,669,836

Holding Weightings of Donald Frail


Donald Frail Form 4 Trading Tracker

According to the SEC Form 4 filings, Donald Frail has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 10,000 shares on July 21, 2020, which cost Donald Frail around $180,000.

Insider Trading History of Donald Frail

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Donald Frail Trading Performance

GuruFocus tracks the stock performance after each of Donald Frail's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald Frail is -38.63%. GuruFocus also compares Donald Frail's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald Frail within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Donald Frail's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Donald Frail

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.94 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.35 LIMIT LIMIT LIMIT LIMIT LIMIT

Donald Frail Ownership Network

Ownership Network List of Donald Frail

No Data

Ownership Network Relation of Donald Frail

Insider Network Chart

Donald Frail Owned Company Details

What does Pandion Therapeutics Inc do?

Who are the key executives at Pandion Therapeutics Inc?

Donald Frail is the director of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , See Remarks Joanne L. Viney , and 10 percent owner Mva Investors, Llc .

Pandion Therapeutics Inc (PAND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pandion Therapeutics Inc Insider Transactions

No Available Data

Donald Frail Mailing Address

Above is the net worth, insider trading, and ownership report for Donald Frail. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Donald Frail's mailing address is: 2nd Floor Watertown Ma 02472.